Advances in the pathogenesis of HIV-associated kidney diseases (Q33415306)

26 July 2017

title

Advances in the pathogenesis of HIV-associated kidney diseases (English)

1 reference

26 July 2017

0 references

1 reference

Michael J Ross

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

14 May 2014

1 reference

26 July 2017

1 reference

26 July 2017

volume

86

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

266-274

1 reference

Trends in Diseases Reported on US Death Certificates That Mentioned HIV Infection, 1996-2006

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Trends in diseases reported on U.S. death certificates that mentioned HIV infection, 1987-1999

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Racial differences in end-stage renal disease rates in HIV infection versus diabetes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Infection of human primary renal epithelial cells with HIV-1 from children with HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Progressive glomerulosclerosis and enhanced renal accumulation of basement membrane components in mice transgenic for human immunodeficiency virus type 1 genes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Quantitative 3D video microscopy of HIV transfer across T cell virological synapses

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Virological synapses allow HIV-1 uptake and gene expression in renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Tubular cell HIV-entry through apoptosed CD4 T cells: a novel pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The kidney as a reservoir for HIV-1 after renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Non-productive HIV-1 infection of human glomerular and urinary podocytes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

DC-specific ICAM-3-grabbing nonintegrin mediates internalization of HIV-1 into human podocytes.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-1 genes vpr and nef synergistically damage podocytes, leading to glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Deployment of the human immunodeficiency virus type 1 protein arsenal: combating the host to enhance viral transcription and providing targets for therapeutic development

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Reduction of Stat3 activity attenuates HIV-induced kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Deletion of podocyte STAT3 mitigates the entire spectrum of HIV-1-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Role of the retinoic acid receptor-α in HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Kruppel-like factor 15 (KLF15) is a key regulator of podocyte differentiation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Activation of Notch signaling pathway in HIV-associated nephropathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Adverse host factors exacerbate occult HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Angiotensin II provokes podocyte injury in murine model of HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Captopril and renal survival in patients with human immunodeficiency virus nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-1 Vpr inhibits cytokinesis in human proximal tubule cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-1 Vpr activates the DNA damage response in renal tubule epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-1 viral protein r induces ERK and caspase-8-dependent apoptosis in renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

A systems approach identifies HIPK2 as a key regulator of kidney fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

NF-kappaB regulates Fas-mediated apoptosis in HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Persistent NF-kappaB activation in renal epithelial cells in a mouse model of HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Down-regulation of NF-κB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Rapamycin-induced modulation of HIV gene transcription attenuates progression of HIVAN.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The clinical spectrum of renal disease associated with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

APOL1 localization in normal kidney and nondiabetic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Plasma apolipoprotein L1 levels do not correlate with CKD.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The APOL1 genotype of African American kidney transplant recipients does not impact 5-year allograft survival

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The APOL1 gene and allograft survival after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The MYH9/APOL1 region and chronic kidney disease in European-Americans

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Genetics, clinical and pathological features of glomerulonephrites associated with mutations of nonmuscle myosin IIA (Fechtner syndrome)

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Podocyte-specific deletion of Myh9 encoding nonmuscle myosin heavy chain 2A predisposes mice to glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Background strain and the differential susceptibility of podocyte-specific deletion of Myh9 on murine models of experimental glomerulosclerosis and HIV nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Glomerular MYH9 expression is reduced by HIV-1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Identification of the nephropathy-susceptibility locus HIVAN4

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Susceptibility loci for murine HIV-associated nephropathy encode trans-regulators of podocyte gene expression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Accelerated development of collapsing glomerulopathy in mice congenic for the HIVAN1 locus

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Expression of HIV transgene aggravates kidney injury in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Glomerular lesions in HIV-positive patients: a 20-year biopsy experience from Northern Italy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Immune complex renal disease and human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-associated immune complex glomerulonephritis with "lupus-like" features: a clinicopathologic study of 14 cases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

HIV-associated immune-mediated renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

A hemolytic-uremic syndrome with the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Thrombotic thrombocytopenic purpura associated with human immunodeficiency virus type 1 (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Thrombotic microangiopathy in patients with acquired immunodeficiency syndrome before and during the era of introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Thrombotic microangiopathy and other glomerular disorders in the HIV-infected patient

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

CKD in HIV-infected patients other than HIV-associated nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Human immunodeficiency virus-associated thrombotic microangiopathies: clinical characteristics and outcome according to ADAMTS13 activity

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Immunodeficiency and renal impairment are risk factors for HIV-associated acute renal failure

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Incidence and etiology of acute renal failure among ambulatory HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Role of ubiquitin-like protein FAT10 in epithelial apoptosis in renal disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Activation of HIV gene expression during monocyte differentiation by induction of NF-kB

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Renal HIV expression is unaffected by serum LPS levels in an HIV transgenic mouse model of LPS induced kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Subclinical tubular injury in HIV-infected individuals on antiretroviral therapy: a cross-sectional analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Predictors of kidney tubular dysfunction in HIV-infected patients treated with tenofovir: a pharmacogenetic study

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Analysis of three-dimensional systems for developing and mature kidneys clarifies the role of OAT1 and OAT3 in antiviral handling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Functional involvement of multidrug resistance-associated protein 4 (MRP4/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Effects of apricitabine and other nucleoside reverse transcriptase inhibitors on replication of mitochondrial DNA in HepG2 cells

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Tenofovir/probenecid combination in HIV/HBV-coinfected patients: how to escape Fanconi syndrome recurrence?

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Indinavir-associated interstitial nephritis and urothelial inflammation: clinical and cytologic findings

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Renal atrophy associated with long-term treatment with indinavir

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Anuria and acute renal failure resulting from indinavir sulfate induced nephrolithiasis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Atazanavir-associated nephrolithiasis: cases from the US Food and Drug Administration's Adverse Event Reporting System

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2014.167

7 January 2021

Identifiers

DOI

10.1038/KI.2014.167

1 reference

Dimensions Publication ID

26 July 2017

1004696321

0 references

1 reference